Clinical Application of Intact Parathyroid Hormone Assays

Ashby JP Newman DJ Gow SM. Clinical application of intact parathyroid hormone assays. Ann Clin Biochem 1997; 34: 588–98.

Quarles LD Lobough B Murphy G. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 1992; 75: 145–50.

Treatment of Adult Patients with Renal Failure. Second Edn. London: Renal Association/Royal College of Physicians, 1997.

Gerakis A Hutchinson AJ Apostolou T Freemont AJ Billis A. Biochemical markers for non-invasive diagnosis of hyperparathyroid disease and adynamic bone in patients on haemodialysis. Nephrol Dial Trans 1996; 11: 2430–8.

Qi Q Monier-Faugere MC Geng Z Malluche HH. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kid Dis. 1995; 26: 622–31.

Couttenye MM D'Haese PC Van Hoof VO Lemoniatou E Goodman W Verpooten GA Low levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients. Nephrol Dial Trans 1996; 11: 1065–72.

Urena P Hruby M Ferreira A Ang KS de Vernejoul MC. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol 1996; 7: 506–12.

Lepage R Whittom S Bertrand S Bahsali G D'Amour P. Superiority of dynamic over static reference intervals for intact, midmolecule and C-terminal parathyrin in evaluating calcium disorders. Clin Chem 1992; 38: 2129–35.

Heath D. Familial hypocalcemia—not hypoparathyroidism. N Engl J Med. 1996; 335: 1144–5.